The biomap® diversity plus panel offers a comprehensive profiling system that includes 12 systems with various primary human cell types for mechanism of action studies and safety and efficacy evaluations in autoimmune and inflammatory diseases. It features over 140 biomarker readouts and supports both single and co-culture formats for diverse biological applications. The process involves high throughput analysis using an automated database, with results typically available in 1 to 8 weeks depending on the system.